16 results on '"Colin, Pieter"'
Search Results
2. Pharmacodynamic mechanism-based interaction model for the haemodynamic effects of remifentanil and propofol in healthy volunteers
3. Mechanism-based pharmacodynamic model for propofol haemodynamic effects in healthy volunteers☆
4. Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment
5. Clinical validation of pharmacokinetic/pharmacodynamic models for propofol infusion. Response to Br J Anaesth 2021: 126: e172-4
6. Optimizing Amoxicillin/Clavulanic Acid Dosing Regimens in Patients on Maintenance High-Flux Hemodialysis
7. Resisting neural inertia: an exercise in floccinaucinihilipilification?
8. Target-controlled-infusion models for remifentanil dosing consistent with approved recommendations
9. A cross-sectional pilot study of student's proactive behavior in midwifery education: Validation of a developed questionnaire
10. A dried blood spot assay for paclitaxel and its metabolites
11. Zwitterionic hydrophilic interaction liquid chromatography-tandem mass spectrometry with HybridSPE-precipitation for the determination of intact cisplatin in human plasma
12. Enzymatic tumour tissue digestion coupled to SPE–UPLC–Tandem Mass Spectrometry as a tool to explore paclitaxel tumour penetration
13. Quantification of cytochrome 2E1 in human liver microsomes using a validated indirect ELISA
14. Development and validation of a fast and uniform approach to quantify β-lactam antibiotics in human plasma by solid phase extraction-liquid chromatography–electrospray-tandem mass spectrometry
15. Development and validation of an enzyme-linked immunosorbent assay for the quantification of cytochrome 3A4 in human liver microsomes
16. Development and validation of a fast and sensitive UPLC–MS/MS method for the quantification of six probe metabolites for the in vitro determination of cytochrome P450 activity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.